Zhejiang Sunflower Great Health (300111.SZ) subsidiary has obtained a drug registration certificate for glucosamine sulfate capsules.
Sunflower (300111.SZ) announced that its subsidiary, Zhejiang Beid Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate for Glucosamine Sulfate Capsules issued by the National Medical Products Administration. This medication is indicated for primary and secondary osteoarthritis. The acquisition of the Drug Registration Certificate is regarded as passing the consistency evaluation.
Zhejiang Sunflower Great Health (300111.SZ) announced that its subsidiary, Zhejiang Beide Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate for Glucosamine Sulfate Capsules issued by the National Medical Products Administration. This medication is indicated for primary and secondary osteoarthritis, and obtaining this Drug Registration Certificate is regarded as passing the consistency evaluation.
Related Articles
Guangdong Zhongsheng Pharmaceutical (002317.SZ): Fenofibrate capsules approved to increase the 0.2g specification.
COSMOS MACH (00118): Non-executive director Jian Weihua has passed away.
CGN NEW ENERGY (01811) spent HKD 963,500 to repurchase 462,000 shares on September 4.
Guangdong Zhongsheng Pharmaceutical (002317.SZ): Fenofibrate capsules approved to increase the 0.2g specification.
COSMOS MACH (00118): Non-executive director Jian Weihua has passed away.
CGN NEW ENERGY (01811) spent HKD 963,500 to repurchase 462,000 shares on September 4.
RECOMMEND
